Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Stock Crosses Above 50-Day Moving Average – Here’s Why

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $31.74 and traded as high as $32.37. Fidelity Disruptive Medicine ETF shares last traded at $32.0360, with a volume of 12,202 shares traded.

Fidelity Disruptive Medicine ETF Stock Up 1.6%

The stock has a market cap of $51.90 million, a price-to-earnings ratio of 34.37 and a beta of 0.76. The business’s 50 day simple moving average is $31.74 and its 200 day simple moving average is $27.85.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently bought a new position in Fidelity Disruptive Medicine ETF stock. Root Financial Partners LLC purchased a new position in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 1,291 shares of the company’s stock, valued at approximately $42,000. Root Financial Partners LLC owned 0.08% of Fidelity Disruptive Medicine ETF as of its most recent filing with the Securities & Exchange Commission.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.